SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Pfizer sues Dr Reddy’s over Lipitor patent

11 Dec 2009 Evaluate

Drug maker Pfizer Inc. sued Dr Reddy’s Laboratories Ltd, asking a judge to prohibit sales of generic versions of its best-selling anti-cholesterol medicine Lipitor until 2017. Dr Reddy’s had notified Pfizer in October that it was seeking US Food and Drug Administration permission to sell copies of Lipitor, and that the patent wasn’t infringed, according to the lawsuit.

 

“Pfizer will be irreparably harmed if Dr Reddy’s is allowed to sell the drug in the US market,” according to Pfizer. New York-based Pfizer has $48.2 billion (Rs2.3 trillion now) in total sales last year and had $12.4 billion in 2008 Lipitor sales, out of which $7.7 billion were in the US. Dr Reddy’s is working to resolve the matter as quickly as possible.

crackcrack

Dr. Reddys Lab Share Price

1232.00 19.65 (1.62%)
10-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1654.70
Dr. Reddys Lab 1232.00
Cipla 1229.60
Zydus Lifesciences 915.45
Lupin 2332.70
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×